1. Home
  2. AVA vs BLLN Comparison

AVA vs BLLN Comparison

Compare AVA & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avista Corporation

AVA

Avista Corporation

HOLD

Current Price

$41.90

Market Cap

3.3B

Sector

Utilities

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$80.90

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVA
BLLN
Founded
1889
2016
Country
United States
United States
Employees
N/A
713
Industry
Power Generation
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
AVA
BLLN
Price
$41.90
$80.90
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$38.67
$126.71
AVG Volume (30 Days)
444.4K
281.7K
Earning Date
05-05-2026
03-04-2026
Dividend Yield
4.66%
N/A
EPS Growth
3.93
N/A
EPS
2.38
N/A
Revenue
$1,964,000,000.00
N/A
Revenue This Year
$2.49
$45.96
Revenue Next Year
$4.27
$30.11
P/E Ratio
$17.66
N/A
Revenue Growth
1.34
N/A
52 Week Low
$35.50
$61.96
52 Week High
$43.50
$138.70

Technical Indicators

Market Signals
Indicator
AVA
BLLN
Relative Strength Index (RSI) 63.29 51.76
Support Level $38.15 $80.39
Resistance Level $43.50 $83.20
Average True Range (ATR) 0.75 6.77
MACD 0.30 1.35
Stochastic Oscillator 90.07 49.68

Price Performance

Historical Comparison
AVA
BLLN

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: